A study conducted by researchers at Northwestern University has concluded that the FDA has largely failed in its responsibility of protecting women from faulty or poorly designed medical devices.
Of the 18 devices approved between 2000 and 2015 for high risk application to women’s medical care; including fetal monitoring, contraception, and uterine bleeding:
Johnson & Johnson’s Ethicon unit suffered a significant loss at the hands of a Philadelphia jury as a 65-year old Indiana woman won a multi-million dollar verdict against the pharmaceutical giant.
Claiming that the mesh implant caused her various medical problems and took away her ability to have sex, Patricia Hammons’ trial took two and a half weeks to complete. It also resulted in quite ...
continue reading...
According to Bloomberg, medical device manufacturer C. R. Bard has agreed to pay more than $200 million to settle over 3,000 transvaginal mesh lawsuits. The news comes from five sources close to the situation, and if true, represents a massive victory for women who suffered from the allegedly defective devices.
Transvaginal mesh implants are designed to prevent urinary incontinence and organ prolapse in women. However, several patients ...
continue reading...
Boston Scientific Corp. has been ordered to pay $100 million to a Delaware woman who claims the company’s transvaginal mesh implants caused her chronic pain and left her unable to have sex. According to Bloomberg, this marks the first verdict returned following Boston Scientific’s agreement to settle 3,000 transvaginal mesh lawsuits.
Transvaginal mesh implants are intended to treat urinary incontinence and ...
continue reading...
Johnson & Johnson Chairman and Chief Executive Alex Gorsky’s total pay rose 48 percent in 2014, an article from the Wall Street Journal Reports. Board members say they made the decision based on Johnson & Johnson’s success in achieving short- and long-term financial goals and building on the momentum of its pharmaceutical business.
Despite these positive reviews, 2014 was a year fraught with ...
continue reading...The first of a series of trials regarding Boston Scientific’s vaginal mesh devices has ended in the company’s favor. Bloomberg reports that a Massachusetts jury found that the plaintiff had not proven that Boston Scientific’s vaginal mesh device, named Pinnacle mesh, was defectively designed. The jury also found that the plaintiff failed to demonstrate that the warnings about the inherent risks of the device were inadequate.
Over 12,000 lawsuits have been filed against ...
continue reading...
